Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Can omega-3 fatty acids prevent chemotherapy side effects? Well, maybe. According to the study linked below. I say “maybe” because the study doesn’t really say that omega-3’s prevent
the study explains the side effect- such as pain- but only talks about omega-3 fatty acids analgesic properties.
Asking Chat GPT gave me more direct answers- see below-
I wish I knew then what I know now. I say this because I have struggles which side effects ranging from chemobrain to chemotherapy-induced cardiomyopathy and many in between. Omega-3 fatty acids supplementation would have helped me… a lot.
Email me at David.PeopleBeatingCancer@gmail.com with your questions about chemotherapy-side effect prevention.
Thank you,
David Emerson
“Omega-3 polyunsaturated fatty acids (PUFAs) are considered immunonutrients and are commonly used in the nutritional therapy of cancer patients due to their ample biological effects. Omega-3 PUFAs play essential roles in cell signaling and in the cell structure and fluidity of membranes.
They participate in the resolution of inflammation and have anti-inflammatory and antinociceptive effects. Additionally, they can act as agonists of G protein-coupled receptors, namely, GPR40/FFA1 and GPR120/FFA4.
Cancer patients undergo complications, such as anorexia-cachexia syndrome, pain, depression, and paraneoplastic syndromes. Interestingly, the 2017 European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines for cancer patients only discuss the use of omega-3 PUFAs for cancer-cachexia treatment, leaving aside other cancer-related complications that could potentially be managed by omega-3 PUFA supplementation.
This critical review aimed to discuss the effects and the possible underlying mechanisms of omega-3 PUFA supplementation in cancer-related complications.
Data compilation in this critical review indicates that further investigation is still required to assess the factual benefits of omega-3 PUFA supplementation in cancer-associated illnesses. Nevertheless, preclinical evidence reveals that omega-3 PUFAs and their metabolites might modulate pivotal pathways underlying complications secondary to cancer, indicating that this is a promising field of knowledge to be explored…
Cancer pain is the most common cancer-related complication, reported by approximately 90% of patients. Unfortunately, up to 50% of these patients are poorly treated for this condition.
Pain in cancer patients occurs because of the tumor growth itself, metastasis development, or treatment-related adverse effects, such as chemotherapy-induced neurotoxicity. Pain in cancer survivors is also important because any change in this condition can indicate a recurrence of the tumor [14,15,17]…
Supporting the favorable analgesic actions of omega-3 PUFAs, a systematic review demonstrated that a nutritional supplement enriched with fish oil decreased the symptoms of fatigue and pain in patients during chemo- and/or radiotherapy, probably due to weight maintenance and reduced inflammatory status [93,94]…
prevent chemotherapy side effects prevent chemotherapy side effects